Sanofi Consumer Healthcare India Limited has informed the Exchange about change in designation of Mr. Viral Shah, Director, External Manufacturing as Senior Management Personnel of the Company.
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India has redesignated two of its directors as Senior Management Personnel (SMP) effective 25th February 2026. Ms. Nupur Gurbaxani, Director of Brand & Innovation (joined July 2024, 18+ years experience at Godrej Consumer Products, Novartis, and Abbott Nutrition), and Mr. Viral Shah, Director of External Manufacturing (joined May 2024, 20+ years experience at Torrent, Ranbaxy, Merck & Co., and Bayer), have been given the SMP tag based on the Nomination & Remuneration Committee's recommendation. Both are existing internal leaders, not new hires, and the change was approved at a board meeting that ran from 2:00 p.m. to 5:20 p.m. on 25th February 2026.
This is a routine regulatory reclassification of existing senior leaders and carries no material impact on the company's operations, financials, or shareholder value. Investors should note it is a structural/designation update rather than a leadership change.